Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tachikawa electrolyzed calcium
- Development stage
- Unknown
- Lead developer
- Morita Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Tachikawa electrolyzed calcium is a specialized liquid calcium preparation developed and manufactured by Morita Pharmaceutical Company. It is produced through an electrolysis process that generates highly bioavailable calcium ions from natural sources (such as oyster shells). While traditionally used as a calcium supplement and classified as a Second-class OTC drug in Japan, it is currently being investigated for its potential therapeutic effects on the behavioral and psychological symptoms of dementia (BPSD) in patients with Alzheimer's disease. The therapeutic rationale is based on the hypothesis that stabilizing calcium homeostasis and modulating neuronal excitability can alleviate symptoms such as agitation, anxiety, and sleep disturbances. Clinical studies, including those conducted at Soujinkai Hospital, have utilized the Neuropsychiatric Inventory-Questionnaire (NPI-Q) and the Dementia Behavior Disturbance Scale (DBD) to evaluate its efficacy.
- Brand names
- Tachikawa Electrolyzed Calcium
- Other names
- Electrolyzed calciumTachikawa Denkai Calcium立川電解カルシウム
02
Targets
CaSR (Extracellular calcium-sensing receptor)
Beyond the preview
Go deeper on Tachikawa electrolyzed calcium.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tachikawa electrolyzed calcium.